Medical polymers used for sutures and stent coatings.
"Poly-DL-lactic acid (PDLLA)" is obtained by using lactide (the cyclic dimer of lactic acid) as a monomer and performing ring-opening polymerization. Unlike crystalline poly-L-lactic acid (PLLA) and poly-D-lactic acid, it has an amorphous structure with L-lactic acid units and D-lactic acid units arranged randomly. It is mainly used for (biodegradable) sutures and stent coatings, and recently, development for new absorbable devices is also underway. 【Features】 ■ Mainly used for sutures and stent coating applications ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Amorphous, transparent *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications (Example)】 Test Items: Standards ■ Inherent Viscosity: ηinh = 0.85 − 1.15 (dL/g) [0.5 g/dL CHCl3, 25 ℃] ■ Molecular Weight (MW): (Reference value: MW = 100,000 − 180,000) ■ Glass Transition Temperature (Tg): (Reference value: Tg = 50 − 60 (℃)) ■ Particle Size: Must not pass through a sieve with an opening of 500 µm *This is the specification for our representative PDLLA polymer. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage】 ■Solution: Coating agent ■Other: New medical device *For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Institute for Frontier Medical Sciences at Kyoto University. Since its founding, the company has focused on the field of medical polymers to realize its corporate philosophy of "contributing to the health of people around the world by working on the development of better medical biomaterial products and providing innovative solutions in the medical field," supporting advancements in biomaterials technology and people's health across three business areas.
